Global Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.
Oral Vaccines segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.
Oral Vaccines segment by Company
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Oral Vaccines Market Size, 2019 VS 2023 VS 2030
1.3 Global Oral Vaccines Market Size Estimates and Forecasts (2019-2030)
1.4 Global Oral Vaccines Sales Estimates and Forecasts (2019-2030)
1.5 Global Oral Vaccines Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL ORAL VACCINES MARKET DYNAMICS
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 ORAL VACCINES MARKET BY MANUFACTURERS
3.1 Global Oral Vaccines Revenue by Manufacturers (2019-2024)
3.2 Global Oral Vaccines Sales by Manufacturers (2019-2024)
3.3 Global Oral Vaccines Average Sales Price by Manufacturers (2019-2024)
3.4 Global Oral Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oral Vaccines Manufacturers, Product Type & Application
3.7 Global Oral Vaccines Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Oral Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier
4 ORAL VACCINES MARKET BY TYPE
4.1 Oral Vaccines Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Cholera Vaccine
4.1.3 Oral Polio Vaccine
4.2 Global Oral Vaccines Sales by Type
4.2.1 Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Oral Vaccines Sales by Type (2019-2030)
4.2.3 Global Oral Vaccines Sales Market Share by Type (2019-2030)
4.3 Global Oral Vaccines Revenue by Type
4.3.1 Global Oral Vaccines Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Oral Vaccines Revenue by Type (2019-2030)
4.3.3 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
5 ORAL VACCINES MARKET BY APPLICATION
5.1 Oral Vaccines Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Sales by Application
5.2.1 Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Oral Vaccines Sales by Application (2019-2030)
5.2.3 Global Oral Vaccines Sales Market Share by Application (2019-2030)
5.3 Global Oral Vaccines Revenue by Application
5.3.1 Global Oral Vaccines Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Oral Vaccines Revenue by Application (2019-2030)
5.3.3 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
6 GLOBAL ORAL VACCINES SALES BY REGION
6.1 Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Oral Vaccines Sales by Region (2019-2030)
6.2.1 Global Oral Vaccines Sales by Region (2019-2024)
6.2.2 Global Oral Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Oral Vaccines Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Oral Vaccines Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Oral Vaccines Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL ORAL VACCINES REVENUE BY REGION
7.1 Global Oral Vaccines Revenue by Region
7.1.1 Global Oral Vaccines Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Oral Vaccines Revenue by Region (2019-2024)
7.1.3 Global Oral Vaccines Revenue by Region (2025-2030)
7.1.4 Global Oral Vaccines Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Oral Vaccines Revenue (2019-2030)
7.2.2 North America Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Oral Vaccines Revenue (2019-2030)
7.3.2 Europe Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oral Vaccines Revenue (2019-2030)
7.4.2 Asia-Pacific Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Oral Vaccines Revenue (2019-2030)
7.5.2 LAMEA Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Oral Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Oral Vaccines Product Portfolio
8.2.5 GSK Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Sanofi Oral Vaccines Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Lanzhou Institute
8.4.1 Lanzhou Institute Comapny Information
8.4.2 Lanzhou Institute Business Overview
8.4.3 Lanzhou Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
8.4.5 Lanzhou Institute Recent Developments
8.5 Serum Institute
8.5.1 Serum Institute Comapny Information
8.5.2 Serum Institute Business Overview
8.5.3 Serum Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Serum Institute Oral Vaccines Product Portfolio
8.5.5 Serum Institute Recent Developments
8.6 Valneva
8.6.1 Valneva Comapny Information
8.6.2 Valneva Business Overview
8.6.3 Valneva Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Valneva Oral Vaccines Product Portfolio
8.6.5 Valneva Recent Developments
8.7 Shanghai United Cell
8.7.1 Shanghai United Cell Comapny Information
8.7.2 Shanghai United Cell Business Overview
8.7.3 Shanghai United Cell Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
8.7.5 Shanghai United Cell Recent Developments
8.8 Bibcol
8.8.1 Bibcol Comapny Information
8.8.2 Bibcol Business Overview
8.8.3 Bibcol Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Bibcol Oral Vaccines Product Portfolio
8.8.5 Bibcol Recent Developments
8.9 PaxVax
8.9.1 PaxVax Comapny Information
8.9.2 PaxVax Business Overview
8.9.3 PaxVax Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 PaxVax Oral Vaccines Product Portfolio
8.9.5 PaxVax Recent Developments
8.10 Vabiotech
8.10.1 Vabiotech Comapny Information
8.10.2 Vabiotech Business Overview
8.10.3 Vabiotech Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Vabiotech Oral Vaccines Product Portfolio
8.10.5 Vabiotech Recent Developments
8.11 Tiantan Biological
8.11.1 Tiantan Biological Comapny Information
8.11.2 Tiantan Biological Business Overview
8.11.3 Tiantan Biological Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
8.11.5 Tiantan Biological Recent Developments
8.12 EuBiologics
8.12.1 EuBiologics Comapny Information
8.12.2 EuBiologics Business Overview
8.12.3 EuBiologics Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 EuBiologics Oral Vaccines Product Portfolio
8.12.5 EuBiologics Recent Developments
8.13 Panacea Biotec Ltd
8.13.1 Panacea Biotec Ltd Comapny Information
8.13.2 Panacea Biotec Ltd Business Overview
8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
8.13.5 Panacea Biotec Ltd Recent Developments
8.14 Bio-Med
8.14.1 Bio-Med Comapny Information
8.14.2 Bio-Med Business Overview
8.14.3 Bio-Med Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Bio-Med Oral Vaccines Product Portfolio
8.14.5 Bio-Med Recent Developments
8.15 Halfkin Bio-Pharmaceuticals
8.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Oral Vaccines Value Chain Analysis
9.1.1 Oral Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccines Production Mode & Process
9.2 Oral Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccines Distributors
9.2.3 Oral Vaccines Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Oral Vaccines Market Size, 2019 VS 2023 VS 2030
1.3 Global Oral Vaccines Market Size Estimates and Forecasts (2019-2030)
1.4 Global Oral Vaccines Sales Estimates and Forecasts (2019-2030)
1.5 Global Oral Vaccines Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL ORAL VACCINES MARKET DYNAMICS
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 ORAL VACCINES MARKET BY MANUFACTURERS
3.1 Global Oral Vaccines Revenue by Manufacturers (2019-2024)
3.2 Global Oral Vaccines Sales by Manufacturers (2019-2024)
3.3 Global Oral Vaccines Average Sales Price by Manufacturers (2019-2024)
3.4 Global Oral Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Oral Vaccines Manufacturers, Product Type & Application
3.7 Global Oral Vaccines Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Oral Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier
4 ORAL VACCINES MARKET BY TYPE
4.1 Oral Vaccines Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Cholera Vaccine
4.1.3 Oral Polio Vaccine
4.2 Global Oral Vaccines Sales by Type
4.2.1 Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Oral Vaccines Sales by Type (2019-2030)
4.2.3 Global Oral Vaccines Sales Market Share by Type (2019-2030)
4.3 Global Oral Vaccines Revenue by Type
4.3.1 Global Oral Vaccines Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Oral Vaccines Revenue by Type (2019-2030)
4.3.3 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
5 ORAL VACCINES MARKET BY APPLICATION
5.1 Oral Vaccines Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Sales by Application
5.2.1 Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Oral Vaccines Sales by Application (2019-2030)
5.2.3 Global Oral Vaccines Sales Market Share by Application (2019-2030)
5.3 Global Oral Vaccines Revenue by Application
5.3.1 Global Oral Vaccines Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Oral Vaccines Revenue by Application (2019-2030)
5.3.3 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
6 GLOBAL ORAL VACCINES SALES BY REGION
6.1 Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Oral Vaccines Sales by Region (2019-2030)
6.2.1 Global Oral Vaccines Sales by Region (2019-2024)
6.2.2 Global Oral Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Oral Vaccines Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Oral Vaccines Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Oral Vaccines Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL ORAL VACCINES REVENUE BY REGION
7.1 Global Oral Vaccines Revenue by Region
7.1.1 Global Oral Vaccines Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Oral Vaccines Revenue by Region (2019-2024)
7.1.3 Global Oral Vaccines Revenue by Region (2025-2030)
7.1.4 Global Oral Vaccines Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Oral Vaccines Revenue (2019-2030)
7.2.2 North America Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Oral Vaccines Revenue (2019-2030)
7.3.2 Europe Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Oral Vaccines Revenue (2019-2030)
7.4.2 Asia-Pacific Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Oral Vaccines Revenue (2019-2030)
7.5.2 LAMEA Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Oral Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Oral Vaccines Product Portfolio
8.2.5 GSK Recent Developments
8.3 Sanofi
8.3.1 Sanofi Comapny Information
8.3.2 Sanofi Business Overview
8.3.3 Sanofi Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Sanofi Oral Vaccines Product Portfolio
8.3.5 Sanofi Recent Developments
8.4 Lanzhou Institute
8.4.1 Lanzhou Institute Comapny Information
8.4.2 Lanzhou Institute Business Overview
8.4.3 Lanzhou Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
8.4.5 Lanzhou Institute Recent Developments
8.5 Serum Institute
8.5.1 Serum Institute Comapny Information
8.5.2 Serum Institute Business Overview
8.5.3 Serum Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Serum Institute Oral Vaccines Product Portfolio
8.5.5 Serum Institute Recent Developments
8.6 Valneva
8.6.1 Valneva Comapny Information
8.6.2 Valneva Business Overview
8.6.3 Valneva Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Valneva Oral Vaccines Product Portfolio
8.6.5 Valneva Recent Developments
8.7 Shanghai United Cell
8.7.1 Shanghai United Cell Comapny Information
8.7.2 Shanghai United Cell Business Overview
8.7.3 Shanghai United Cell Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
8.7.5 Shanghai United Cell Recent Developments
8.8 Bibcol
8.8.1 Bibcol Comapny Information
8.8.2 Bibcol Business Overview
8.8.3 Bibcol Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Bibcol Oral Vaccines Product Portfolio
8.8.5 Bibcol Recent Developments
8.9 PaxVax
8.9.1 PaxVax Comapny Information
8.9.2 PaxVax Business Overview
8.9.3 PaxVax Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 PaxVax Oral Vaccines Product Portfolio
8.9.5 PaxVax Recent Developments
8.10 Vabiotech
8.10.1 Vabiotech Comapny Information
8.10.2 Vabiotech Business Overview
8.10.3 Vabiotech Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Vabiotech Oral Vaccines Product Portfolio
8.10.5 Vabiotech Recent Developments
8.11 Tiantan Biological
8.11.1 Tiantan Biological Comapny Information
8.11.2 Tiantan Biological Business Overview
8.11.3 Tiantan Biological Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
8.11.5 Tiantan Biological Recent Developments
8.12 EuBiologics
8.12.1 EuBiologics Comapny Information
8.12.2 EuBiologics Business Overview
8.12.3 EuBiologics Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 EuBiologics Oral Vaccines Product Portfolio
8.12.5 EuBiologics Recent Developments
8.13 Panacea Biotec Ltd
8.13.1 Panacea Biotec Ltd Comapny Information
8.13.2 Panacea Biotec Ltd Business Overview
8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
8.13.5 Panacea Biotec Ltd Recent Developments
8.14 Bio-Med
8.14.1 Bio-Med Comapny Information
8.14.2 Bio-Med Business Overview
8.14.3 Bio-Med Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Bio-Med Oral Vaccines Product Portfolio
8.14.5 Bio-Med Recent Developments
8.15 Halfkin Bio-Pharmaceuticals
8.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Oral Vaccines Value Chain Analysis
9.1.1 Oral Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccines Production Mode & Process
9.2 Oral Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccines Distributors
9.2.3 Oral Vaccines Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Oral Vaccines Industry Trends
Table 2. Oral Vaccines Industry Drivers
Table 3. Oral Vaccines Industry Opportunities and Challenges
Table 4. Oral Vaccines Industry Restraints
Table 5. Global Oral Vaccines Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Oral Vaccines Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Oral Vaccines Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Oral Vaccines Sales Market Share by Manufacturers
Table 9. Global Oral Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 10. Global Oral Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Oral Vaccines Manufacturers, Product Type & Application
Table 13. Global Oral Vaccines Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Rotavirus Vaccine
Table 17. Major Manufacturers of Cholera Vaccine
Table 18. Major Manufacturers of Oral Polio Vaccine
Table 19. Global Oral Vaccines Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 21. Global Oral Vaccines Sales by Type (2025-2030) & (M Doses)
Table 22. Global Oral Vaccines Sales Market Share by Type (2019-2024)
Table 23. Global Oral Vaccines Sales Market Share by Type (2025-2030)
Table 24. Global Oral Vaccines Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 25. Global Oral Vaccines Revenue by Type (2019-2024) & (M Doses)
Table 26. Global Oral Vaccines Revenue by Type (2025-2030) & (M Doses)
Table 27. Global Oral Vaccines Revenue Market Share by Type (2019-2024)
Table 28. Global Oral Vaccines Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Public
Table 30. Major Manufacturers of Private
Table 31. Global Oral Vaccines Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 33. Global Oral Vaccines Sales by Application (2025-2030) & (M Doses)
Table 34. Global Oral Vaccines Sales Market Share by Application (2019-2024)
Table 35. Global Oral Vaccines Sales Market Share by Application (2025-2030)
Table 36. Global Oral Vaccines Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 37. Global Oral Vaccines Revenue by Application (2019-2024) & (M Doses)
Table 38. Global Oral Vaccines Revenue by Application (2025-2030) & (M Doses)
Table 39. Global Oral Vaccines Revenue Market Share by Application (2019-2024)
Table 40. Global Oral Vaccines Revenue Market Share by Application (2025-2030)
Table 41. Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Oral Vaccines Sales by Region (2019-2024) & (M Doses)
Table 43. Global Oral Vaccines Sales Market Share by Region (2019-2024)
Table 44. Global Oral Vaccines Sales Forecasted by Region (2025-2030) & (M Doses)
Table 45. Global Oral Vaccines Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 47. North America Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 48. North America Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 49. Europe Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. Europe Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 51. Europe Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 52. Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Asia Pacific Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 54. Asia Pacific Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 55. LAMEA Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. LAMEA Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 57. LAMEA Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 58. Global Oral Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Oral Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Oral Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Oral Vaccines Revenue Market Share by Region (2019-2024)
Table 62. Global Oral Vaccines Revenue Market Share by Region (2025-2030)
Table 63. Merck Company Information
Table 64. Merck Business Overview
Table 65. Merck Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. Merck Oral Vaccines Product Portfolio
Table 67. Merck Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. GSK Oral Vaccines Product Portfolio
Table 72. GSK Recent Development
Table 73. Sanofi Company Information
Table 74. Sanofi Business Overview
Table 75. Sanofi Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. Sanofi Oral Vaccines Product Portfolio
Table 77. Sanofi Recent Development
Table 78. Lanzhou Institute Company Information
Table 79. Lanzhou Institute Business Overview
Table 80. Lanzhou Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Lanzhou Institute Oral Vaccines Product Portfolio
Table 82. Lanzhou Institute Recent Development
Table 83. Serum Institute Company Information
Table 84. Serum Institute Business Overview
Table 85. Serum Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Serum Institute Oral Vaccines Product Portfolio
Table 87. Serum Institute Recent Development
Table 88. Valneva Company Information
Table 89. Valneva Business Overview
Table 90. Valneva Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. Valneva Oral Vaccines Product Portfolio
Table 92. Valneva Recent Development
Table 93. Shanghai United Cell Company Information
Table 94. Shanghai United Cell Business Overview
Table 95. Shanghai United Cell Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Shanghai United Cell Oral Vaccines Product Portfolio
Table 97. Shanghai United Cell Recent Development
Table 98. Bibcol Company Information
Table 99. Bibcol Business Overview
Table 100. Bibcol Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. Bibcol Oral Vaccines Product Portfolio
Table 102. Bibcol Recent Development
Table 103. PaxVax Company Information
Table 104. PaxVax Business Overview
Table 105. PaxVax Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. PaxVax Oral Vaccines Product Portfolio
Table 107. PaxVax Recent Development
Table 108. Vabiotech Company Information
Table 109. Vabiotech Business Overview
Table 110. Vabiotech Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. Vabiotech Oral Vaccines Product Portfolio
Table 112. Vabiotech Recent Development
Table 113. Tiantan Biological Company Information
Table 114. Tiantan Biological Business Overview
Table 115. Tiantan Biological Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. Tiantan Biological Oral Vaccines Product Portfolio
Table 117. Tiantan Biological Recent Development
Table 118. EuBiologics Company Information
Table 119. EuBiologics Business Overview
Table 120. EuBiologics Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. EuBiologics Oral Vaccines Product Portfolio
Table 122. EuBiologics Recent Development
Table 123. Panacea Biotec Ltd Company Information
Table 124. Panacea Biotec Ltd Business Overview
Table 125. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 127. Panacea Biotec Ltd Recent Development
Table 128. Bio-Med Company Information
Table 129. Bio-Med Business Overview
Table 130. Bio-Med Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 131. Bio-Med Oral Vaccines Product Portfolio
Table 132. Bio-Med Recent Development
Table 133. Halfkin Bio-Pharmaceuticals Company Information
Table 134. Halfkin Bio-Pharmaceuticals Business Overview
Table 135. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 137. Halfkin Bio-Pharmaceuticals Recent Development
Table 138. Key Raw Materials
Table 139. Raw Materials Key Suppliers
Table 140. Oral Vaccines Distributors List
Table 141. Oral Vaccines Customers List
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources
Table 1. Oral Vaccines Industry Trends
Table 2. Oral Vaccines Industry Drivers
Table 3. Oral Vaccines Industry Opportunities and Challenges
Table 4. Oral Vaccines Industry Restraints
Table 5. Global Oral Vaccines Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Oral Vaccines Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Oral Vaccines Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Oral Vaccines Sales Market Share by Manufacturers
Table 9. Global Oral Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 10. Global Oral Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Oral Vaccines Manufacturers, Product Type & Application
Table 13. Global Oral Vaccines Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Rotavirus Vaccine
Table 17. Major Manufacturers of Cholera Vaccine
Table 18. Major Manufacturers of Oral Polio Vaccine
Table 19. Global Oral Vaccines Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 21. Global Oral Vaccines Sales by Type (2025-2030) & (M Doses)
Table 22. Global Oral Vaccines Sales Market Share by Type (2019-2024)
Table 23. Global Oral Vaccines Sales Market Share by Type (2025-2030)
Table 24. Global Oral Vaccines Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 25. Global Oral Vaccines Revenue by Type (2019-2024) & (M Doses)
Table 26. Global Oral Vaccines Revenue by Type (2025-2030) & (M Doses)
Table 27. Global Oral Vaccines Revenue Market Share by Type (2019-2024)
Table 28. Global Oral Vaccines Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Public
Table 30. Major Manufacturers of Private
Table 31. Global Oral Vaccines Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 32. Global Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 33. Global Oral Vaccines Sales by Application (2025-2030) & (M Doses)
Table 34. Global Oral Vaccines Sales Market Share by Application (2019-2024)
Table 35. Global Oral Vaccines Sales Market Share by Application (2025-2030)
Table 36. Global Oral Vaccines Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 37. Global Oral Vaccines Revenue by Application (2019-2024) & (M Doses)
Table 38. Global Oral Vaccines Revenue by Application (2025-2030) & (M Doses)
Table 39. Global Oral Vaccines Revenue Market Share by Application (2019-2024)
Table 40. Global Oral Vaccines Revenue Market Share by Application (2025-2030)
Table 41. Global Oral Vaccines Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 42. Global Oral Vaccines Sales by Region (2019-2024) & (M Doses)
Table 43. Global Oral Vaccines Sales Market Share by Region (2019-2024)
Table 44. Global Oral Vaccines Sales Forecasted by Region (2025-2030) & (M Doses)
Table 45. Global Oral Vaccines Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 47. North America Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 48. North America Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 49. Europe Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. Europe Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 51. Europe Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 52. Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Asia Pacific Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 54. Asia Pacific Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 55. LAMEA Oral Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. LAMEA Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 57. LAMEA Oral Vaccines Sales by Country (2025-2030) & (M Doses)
Table 58. Global Oral Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Oral Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Oral Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Oral Vaccines Revenue Market Share by Region (2019-2024)
Table 62. Global Oral Vaccines Revenue Market Share by Region (2025-2030)
Table 63. Merck Company Information
Table 64. Merck Business Overview
Table 65. Merck Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. Merck Oral Vaccines Product Portfolio
Table 67. Merck Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. GSK Oral Vaccines Product Portfolio
Table 72. GSK Recent Development
Table 73. Sanofi Company Information
Table 74. Sanofi Business Overview
Table 75. Sanofi Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. Sanofi Oral Vaccines Product Portfolio
Table 77. Sanofi Recent Development
Table 78. Lanzhou Institute Company Information
Table 79. Lanzhou Institute Business Overview
Table 80. Lanzhou Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Lanzhou Institute Oral Vaccines Product Portfolio
Table 82. Lanzhou Institute Recent Development
Table 83. Serum Institute Company Information
Table 84. Serum Institute Business Overview
Table 85. Serum Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Serum Institute Oral Vaccines Product Portfolio
Table 87. Serum Institute Recent Development
Table 88. Valneva Company Information
Table 89. Valneva Business Overview
Table 90. Valneva Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. Valneva Oral Vaccines Product Portfolio
Table 92. Valneva Recent Development
Table 93. Shanghai United Cell Company Information
Table 94. Shanghai United Cell Business Overview
Table 95. Shanghai United Cell Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Shanghai United Cell Oral Vaccines Product Portfolio
Table 97. Shanghai United Cell Recent Development
Table 98. Bibcol Company Information
Table 99. Bibcol Business Overview
Table 100. Bibcol Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. Bibcol Oral Vaccines Product Portfolio
Table 102. Bibcol Recent Development
Table 103. PaxVax Company Information
Table 104. PaxVax Business Overview
Table 105. PaxVax Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. PaxVax Oral Vaccines Product Portfolio
Table 107. PaxVax Recent Development
Table 108. Vabiotech Company Information
Table 109. Vabiotech Business Overview
Table 110. Vabiotech Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. Vabiotech Oral Vaccines Product Portfolio
Table 112. Vabiotech Recent Development
Table 113. Tiantan Biological Company Information
Table 114. Tiantan Biological Business Overview
Table 115. Tiantan Biological Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. Tiantan Biological Oral Vaccines Product Portfolio
Table 117. Tiantan Biological Recent Development
Table 118. EuBiologics Company Information
Table 119. EuBiologics Business Overview
Table 120. EuBiologics Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. EuBiologics Oral Vaccines Product Portfolio
Table 122. EuBiologics Recent Development
Table 123. Panacea Biotec Ltd Company Information
Table 124. Panacea Biotec Ltd Business Overview
Table 125. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 127. Panacea Biotec Ltd Recent Development
Table 128. Bio-Med Company Information
Table 129. Bio-Med Business Overview
Table 130. Bio-Med Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 131. Bio-Med Oral Vaccines Product Portfolio
Table 132. Bio-Med Recent Development
Table 133. Halfkin Bio-Pharmaceuticals Company Information
Table 134. Halfkin Bio-Pharmaceuticals Business Overview
Table 135. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 137. Halfkin Bio-Pharmaceuticals Recent Development
Table 138. Key Raw Materials
Table 139. Raw Materials Key Suppliers
Table 140. Oral Vaccines Distributors List
Table 141. Oral Vaccines Customers List
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources
LIST OF FIGURES
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
Figure 4. Global Oral Vaccines Sales (2019-2030) & (M Doses)
Figure 5. Global Oral Vaccines Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Rotavirus Vaccine Picture
Figure 9. Cholera Vaccine Picture
Figure 10. Oral Polio Vaccine Picture
Figure 11. Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Oral Vaccines Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Oral Vaccines Sales Market Share by Type (2019-2030)
Figure 14. Global Oral Vaccines Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 15. Global Oral Vaccines Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Oral Vaccines Revenue Market Share by Type (2019-2030)
Figure 17. Public Picture
Figure 18. Private Picture
Figure 19. Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Oral Vaccines Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Oral Vaccines Sales Market Share by Application (2019-2030)
Figure 22. Global Oral Vaccines Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Oral Vaccines Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Oral Vaccines Revenue Market Share by Application (2019-2030)
Figure 25. North America Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 26. North America Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 27. U.S. Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Canada Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 30. Europe Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 31. Germany Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. France Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. U.K. Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Italy Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Netherlands Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Asia Pacific Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 38. China Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Japan Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. South Korea Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. Southeast Asia Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. India Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. Australia Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. LAMEA Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Mexico Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Brazil Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. Turkey Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. GCC Countries Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 50. Global Oral Vaccines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Oral Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 53. North America Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Oral Vaccines Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Oral Vaccines Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
Figure 4. Global Oral Vaccines Sales (2019-2030) & (M Doses)
Figure 5. Global Oral Vaccines Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Rotavirus Vaccine Picture
Figure 9. Cholera Vaccine Picture
Figure 10. Oral Polio Vaccine Picture
Figure 11. Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Oral Vaccines Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Oral Vaccines Sales Market Share by Type (2019-2030)
Figure 14. Global Oral Vaccines Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 15. Global Oral Vaccines Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Oral Vaccines Revenue Market Share by Type (2019-2030)
Figure 17. Public Picture
Figure 18. Private Picture
Figure 19. Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 20. Global Oral Vaccines Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Oral Vaccines Sales Market Share by Application (2019-2030)
Figure 22. Global Oral Vaccines Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Oral Vaccines Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Oral Vaccines Revenue Market Share by Application (2019-2030)
Figure 25. North America Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 26. North America Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 27. U.S. Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Canada Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 30. Europe Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 31. Germany Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. France Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. U.K. Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Italy Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Netherlands Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Asia Pacific Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 38. China Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Japan Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. South Korea Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. Southeast Asia Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. India Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. Australia Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. LAMEA Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Mexico Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Brazil Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. Turkey Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. GCC Countries Oral Vaccines Sales and Growth Rate (2019-2030) & (M Doses)
Figure 50. Global Oral Vaccines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Oral Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 53. North America Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Oral Vaccines Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Oral Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Oral Vaccines Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Oral Vaccines Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
